SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-243361
Filing Date
2017-08-01
Accepted
2017-08-01 09:23:05
Documents
4
Period of Report
2017-07-31
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d431976d8k.htm 8-K 39470
2 EX-3.1 d431976dex31.htm EX-3.1 8074
3 EX-99.1 d431976dex991.htm EX-99.1 8551
4 GRAPHIC g431976g28h10.jpg GRAPHIC 4681
  Complete submission text file 0001193125-17-243361.txt   63952
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 17995229
SIC: 2834 Pharmaceutical Preparations